The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 02, 2018

Filed:

Nov. 20, 2017
Applicant:

Ocusoft, Inc., Richmond, TX (US);

Inventors:

Nat Adkins, Jr., Richmond, TX (US);

Cynthia Barratt, Richmond, TX (US);

Assignee:

OCuSOFT, Inc., Richmond, TX (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/68 (2006.01); A61K 8/42 (2006.01); A61K 8/86 (2006.01); A61K 8/60 (2006.01); A61K 8/04 (2006.01); A61K 33/20 (2006.01); A61K 9/00 (2006.01); A61K 8/34 (2006.01); A61K 8/44 (2006.01); A61K 8/55 (2006.01); A61K 8/88 (2006.01); A61K 8/20 (2006.01); A61K 8/49 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/14 (2017.01); A61Q 19/00 (2006.01); A61Q 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 8/68 (2013.01); A61K 8/046 (2013.01); A61K 8/20 (2013.01); A61K 8/345 (2013.01); A61K 8/42 (2013.01); A61K 8/442 (2013.01); A61K 8/4973 (2013.01); A61K 8/553 (2013.01); A61K 8/602 (2013.01); A61K 8/86 (2013.01); A61K 8/88 (2013.01); A61K 9/0048 (2013.01); A61K 33/20 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61Q 19/005 (2013.01); A61Q 19/007 (2013.01); A61Q 19/10 (2013.01); A61K 2800/49 (2013.01); A61K 2800/524 (2013.01); A61K 2800/87 (2013.01); A61K 2800/884 (2013.01);
Abstract

A method for treating an ocular condition involves cleansing an eyelid with a first ophthalmic composition, wherein the first ophthalmic composition consists essentially of water, PEG-80 sorbitan laurate, methyl gluceth-20, PEG-120 methyl glucose dioleate, salicyloyl phytosphingosine, decyl glucoside, 1,2 hexanediol, caprylyl glycol, disodium cocoamphodiacetate, panthenol, polyaminopropyl biguanide, sodium chloride, potassium chloride and calcium chloride followed by applying a therapeutically effective amount of a second ophthalmic composition to a margin of the eyelid, wherein the second ophthalmic composition consists essentially of water and hypochlorous acid.


Find Patent Forward Citations

Loading…